Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Mepolizumab Has No Clinical Impact on Eosinophilic Esophagitis
Link ID 21780
Title Mepolizumab Has No Clinical Impact on Eosinophilic Esophagitis
Url http://www.medscape.com/viewarticle/715320?src=rss
Description Treatment with mepolizumab, a humanized anti-interleukin-5 monoclonal antibody, does not have a major effect in adults with active eosinophilic esophagitis, researchers report in the January issue of Gut. Reuters Health Information
Category Articles > Gastroenterology
Keywords
Date Jan 20, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Gastroenterology
1. Latest Results (12-21 Years) of a Prospective Randomized Study Comparing Billroth II and Roux-en-Y A
  Duodenal ulcer outcomes are examined among patients prospectively randomized to either a partial distal gastrectomy or a Billroth II or Roux-en-Y reconstruction.
Annals of Surgery
Category:   Articles > Gastroenterology


2. Cetuximab and Panitumumab Equally Effective in Colorectal Cancer
  Medscape Medical News
Category:   Articles > Gastroenterology


3. The Emergence of Biomarkers in Treatment for Metastatic Colorectal Cancer: An Expert Interview With
  In this Expert Interview from ASCO 2008, Dr. Neal Meropol discusses practice-changing implications of newly reported findings regarding K-RAS status and other biomarker assessments. Medscape Hematology-Oncology
Category:   Articles > Gastroenterology


4. Screening for Lynch Syndrome in Young Colon Cancer PatientsScreening for Lynch Syndrome in Young Col
  Colon cancer before the age of 50 might be an indication that the patient has Lynch syndrome; screening can identify these individuals. br / iMedscape Medical News/i
Category:   Articles > Gastroenterology


5. Lactulose Breath Test No Help in Diagnosing IBS
  Hydrogen breath testing following lactulose ingestion does not differentiate between patients with irritable bowel syndrome (IBS) and controls without the condition, researchers report in the April issue of the American Journal of Gastroenterology. Reuters Health Information
Category:   Articles > Gastroenterology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS